Hormonal
Increased body mass index (BMI) is strongly associated with a higher risk of developing oesophageal adenocarcinoma, colon and rectal cancer in men, biliary tract system cancer, pancreatic cancer, endometrial cancer (premenopausal), kidney cancer, and multiple myeloma.
Maintaining a healthy body weight is a critical, evidence-based strategy for reducing the risk of several major cancers, including colorectal, pancreatic, kidney, and endometrial cancers. This is not just about aesthetics; it is a direct modifiable risk factor. For men, colorectal risk is particularly sensitive to BMI increases. For women, maintaining a healthy weight, especially before menopause, is crucial for endometrial health. Public health guidelines should target these populations for personalized prevention strategies.
An increase in body mass index was associated with a higher risk of developing oesophageal adenocarcinoma; colon and rectal cancer in men; biliary tract system and pancreatic cancer; endometrial cancer in premenopausal women; kidney cancer; and multiple myeloma.
Why this rating
The paper classifies these associations as 'strong evidence' based on rigorous criteria including P<10^-6, >1000 cases, and absence of bias indicators.
Source
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Maria Kyrgiou et al. · BMJ · 2017
DOI 10.1136/bmj.j477
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →